Skip Navigation

JNCI Journal of the National Cancer Institute 1997 89(20):1530-1536; doi:10.1093/jnci/89.20.1530
© 1997 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schlamp, C. L.
Right arrow Articles by Nickells, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlamp, C. L.
Right arrow Articles by Nickells, R. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal Of The National Cancer Institute, Vol 89, 1530-1536, Copyright © 1997 by Oxford University Press


ARTICLES

Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells

CL Schlamp, GL Poulsen, TM Nork and RW Nickells
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison 53792, USA.

BACKGROUND: Retinoblastoma is the most common childhood tumor of the eye, arising from cells that are defective in both copies of the retinoblastoma susceptibility gene (RB1). Most retinoblastoma tumor cells eventually undergo programmed cell death (i.e., apoptosis); however, some cells can acquire the ability to metastasize and become immortal. Transfection of immortal retinoblastoma cells with DNA sequences encoding wild-type p53 protein induces cell death, suggesting that the loss of both RB1 and p53 functions may be required for cell immortalization. We have examined this possibility by characterizing the p53 protein and messenger RNA in six independently isolated, immortalized retinoblastoma cell lines. METHODS: Western blotting methods were used to assess p53 protein level in each cell line, and Cleavase Fragment-Length Polymorphism analysis of complementary DNAs was used to screen for mutations in p53 messenger RNA. Localization of p53 protein in cells of the immortalized lines and in specimens of retinoblastoma tumors was achieved by means of indirect immunofluorescence and immunocytochemistry, respectively. RESULTS: All six immortalized cell lines expressed wild-type p53 messenger RNA and high levels of p53 protein. Although p53 is normally a nuclear protein, the p53 in four of the six cell lines was located predominately in the cytoplasm; in the remaining two cell lines, p53 was localized in both the nucleus and the cytoplasm. Cytoplasmic localization of p53 in retinoblastoma tumor specimens was rare and usually restricted to cells that had invaded adjacent ocular tissues, indicative of the early stages of metastasis. CONCLUSIONS: Some immortalized retinoblastoma cells may exhibit p53 dysfunction through nuclear exclusion of wild- type p53 protein.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
D. Das, K. Wojno, and M. J. Imperiale
BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages
J. Virol., March 15, 2008; 82(6): 2705 - 2714.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. R. Elison, D. Cobrinik, N. Claros, D. H. Abramson, and T. C. Lee
Small Molecule Inhibition of HDM2 Leads to p53-Mediated Cell Death in Retinoblastoma Cells.
Arch Ophthalmol, September 1, 2006; 124(9): 1269 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Galigniana, J. M. Harrell, H. M. O'Hagen, M. Ljungman, and W. B. Pratt
Hsp90-binding Immunophilins Link p53 to Dynein During p53 Transport to the Nucleus
J. Biol. Chem., May 21, 2004; 279(21): 22483 - 22489.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. L. Schlamp, A. T. Thliveris, Y. Li, L. P. Kohl, C. Knop, J. A. Dietz, I. V. Larsen, P. Imesch, L. H. Pinto, and R. W. Nickells
Insertion of the {beta}Geo Promoter Trap into the Fem1c Gene of ROSA3 Mice
Mol. Cell. Biol., May 1, 2004; 24(9): 3794 - 3803.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Mesaeli and C. Phillipson
Impaired p53 Expression, Function, and Nuclear Localization in Calreticulin-deficient Cells
Mol. Biol. Cell, April 1, 2004; 15(4): 1862 - 1870.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Qu, S. Huang, D. Baltzis, A.-M. Rivas-Estilla, O. Pluquet, M. Hatzoglou, C. Koumenis, Y. Taya, A. Yoshimura, and A. E. Koromilas
Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3{beta}
Genes & Dev., February 1, 2004; 18(3): 261 - 277.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Facchetti, D. Uberti, M. Memo, and C. Missale
Nerve Growth Factor Restores p53 Function in Pituitary Tumor Cell Lines via trkA-Mediated Activation of Phosphatidylinositol 3-Kinase
Mol. Endocrinol., January 1, 2004; 18(1): 162 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Moos, K. Edes, P. Cassidy, E. Massuda, and F. A. Fitzpatrick
Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase
J. Biol. Chem., January 3, 2003; 278(2): 745 - 750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. S. Qutob, R. N. Bhattacharjee, E. Pollari, S. P. Yee, and J. Torchia
Microtubule-Dependent Subcellular Redistribution of the Transcriptional Coactivator p/CIP
Mol. Cell. Biol., September 15, 2002; 22(18): 6611 - 6626.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. M. Brownawell, G. J. P. L. Kops, I. G. Macara, and B. M. T. Burgering
Inhibition of Nuclear Import by Protein Kinase B (Akt) Regulates the Subcellular Distribution and Activity of the Forkhead Transcription Factor AFX
Mol. Cell. Biol., May 15, 2001; 21(10): 3534 - 3546.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
C. J. Fabian, B. F. Kimler, C. M. Zalles, J. R. Klemp, S. Kamel, S. Zeiger, and M. S. Mayo
Short-Term Breast Cancer Prediction by Random Periareolar Fine-Needle Aspiration Cytology and the Gail Risk Model
J Natl Cancer Inst, August 2, 2000; 92(15): 1217 - 1227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kuperwasser, J. Pinkas, G. D. Hurlbut, S. P. Naber, and D. J. Jerry
Cytoplasmic Sequestration and Functional Repression of p53 in the Mammary Epithelium Is Reversed by Hormonal Treatment
Cancer Res., May 1, 2000; 60(10): 2723 - 2729.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Zaika, N. Marchenko, and U. M. Moll
Cytoplasmically "Sequestered" Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation
J. Biol. Chem., September 24, 1999; 274(39): 27474 - 27480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-H. Wu and J. Momand
Pyrrolidine Dithiocarbamate Prevents p53 Activation and Promotes p53 Cysteine Residue Oxidation
J. Biol. Chem., July 24, 1998; 273(30): 18898 - 18905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Akakura, M. Yoshida, Y. Yoneda, and S. Horinouchi
A Role for Hsc70 in Regulating Nucleocytoplasmic Transport of a Temperature-sensitive p53 (p53Val-135)
J. Biol. Chem., April 27, 2001; 276(18): 14649 - 14657.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.